To complete this course and receive CEUs both part 1and part 2 must be viewed.
Adults with normal audiograms and self-reported difficulties comprise more than 12% of the entire American population, yet they are not considered candidates for amplification devices. With the advent of hybrid devices, which combine elements of traditional hearing aids with consumer audio devices, adults with subclinical hearing loss now have access to interventions that improve communication and stave off the ill effects of other chronic health-related problems.
- Part 1 - Explores the under-served segments of the hearing care market and how Signia’s Active product line could be used to create value for under-served market segments.
Persons with subclinical hearing loss are an untapped market segment. To provide value to this segment, clinicians need to use different clinical tools to measure the functional communication of adults with subclinical hearing loss.
- Part 2 - Examines the rationale for earlier intervention and the use of the Quick SIN and validated questionnaires to determine the candidacy of the Active and Insio product lines.